THE SINGLE BEST STRATEGY TO USE FOR MBL77

Not all patients with CLL demand therapy. Irrespective of all new improvements, the iwCLL even now suggests watchful observation for patients with asymptomatic sickness.86 This suggestion is based on at least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).: When